| 05/20/2026 3:15 PM | Innoviva (1080014) Issuer Linden Josephine (1517313) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/20/2026 3:20 PM | Innoviva (1080014) Issuer Linden Josephine (1517313) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:21 PM | Innoviva (1080014) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/13/2026 4:21 PM | Armata Pharmaceuticals, Inc. (921114) Subject Armata Pharmaceuticals, Inc. (921114) Subject Innoviva (1080014) Filed by | Form SCHEDULE 13D/A | |
| 05/06/2026 3:29 PM | Innoviva (1080014) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/06/2026 3:19 PM | Innoviva (1080014) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 3:59 PM | Innoviva (1080014) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 4:00 PM | Innoviva (1080014) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 04/29/2026 12:55 PM | Innoviva (1080014) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 03/27/2026 8:54 AM | Innoviva (1080014) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/24/2026 3:51 PM | Innoviva (1080014) Filer | Form DEF 14A | |
Get the Latest News and Ratings for INVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Innoviva and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/25/2026 3:31 PM | Innoviva (1080014) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/12/2026 1:14 PM | Innoviva (1080014) Subject RENAISSANCE TECHNOLOGIES LLC (1037389) Filed by | Form SCHEDULE 13G/A | |
| 01/26/2026 3:05 PM | Armata Pharmaceuticals, Inc. (921114) Subject Armata Pharmaceuticals, Inc. (921114) Subject Innoviva (1080014) Filed by | Form SCHEDULE 13D/A | |
| 01/21/2026 12:21 PM | DIMENSIONAL FUND ADVISORS LP (354204) Filed by Innoviva (1080014) Subject | Form SCHEDULE 13G/A | |
| 11/24/2025 3:17 PM | Basso Stephen (1815707) Reporting Innoviva (1080014) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 3:16 PM | Innoviva (1080014) Issuer Zhen Marianne (1750085) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 8:45 PM | Innoviva (1080014) Issuer Raifeld Pavel (1813426) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 8:45 PM | Basso Stephen (1815707) Reporting Innoviva (1080014) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 3:28 PM | Innoviva (1080014) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2025 3:18 PM | Innoviva (1080014) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/08/2025 2:44 PM | BANK OF NOVA SCOTIA (9631) Filed by Innoviva (1080014) Subject | Form SCHEDULE 13G/A | |
| 09/03/2025 2:23 PM | BANK OF NOVA SCOTIA (9631) Filed by Innoviva (1080014) Subject | Form SCHEDULE 13G/A | |
| 08/22/2025 3:15 PM | Innoviva (1080014) Issuer Zhen Marianne (1750085) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/22/2025 3:15 PM | Basso Stephen (1815707) Reporting Innoviva (1080014) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2025 8:38 PM | Armata Pharmaceuticals, Inc. (921114) Subject Armata Pharmaceuticals, Inc. (921114) Subject Innoviva (1080014) Filed by | Form SCHEDULE 13D/A | |
| 08/06/2025 3:27 PM | Innoviva (1080014) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |